GUGGENHEIM CAPITAL LLC - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 43 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q3 2016$16,000
+220.0%
26,429
+123.5%
0.00%
Q2 2016$5,000
-61.5%
11,827
-7.6%
0.00%
Q1 2016$13,000
-80.0%
12,794
-41.9%
0.00%
Q4 2015$65,000
+41.3%
22,024
+51.1%
0.00%
Q3 2015$46,000
-23.3%
14,571
+42.8%
0.00%
Q2 2015$60,000
-45.9%
10,207
-17.3%
0.00%
Q2 2014$111,000
+26.1%
12,349
-24.9%
0.00%
Q1 2014$88,000
+151.4%
16,451
+19.2%
0.00%
Q4 2013$35,00013,7990.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q4 2013
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 4,800,000$15,168,0005.18%
Avoro Capital Advisors LLC 6,004,564$18,974,0004.93%
DG Capital Management, LLC 695,808$2,199,0002.56%
ACUTA CAPITAL PARTNERS, LLC 1,108,719$3,504,0002.03%
Aisling Capital LLC 2,010,000$6,352,0001.12%
Broadfin Capital, LLC 6,090,829$19,247,0001.07%
KOPP INVESTMENT ADVISORS LLC 375,293$1,186,0000.64%
SEARLE & CO. 172,500$545,0000.56%
Elk Creek Partners, LLC 1,864,515$5,892,0000.48%
WALL STREET ASSOCIATES 696,300$2,200,0000.42%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders